Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IKT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
20 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 5
106 filers reported a long position in IKT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Sands Capital Alternatives, LLC | $26.4M | 13M | Unchanged |
| Soleus Capital Management, L.P. | $22.1M | 10.9M | Unchanged |
| Trails Edge Capital Partners, LP | $18.4M | 9.1M | +12.3% |
| Fairmount Funds Management LLC | $17.5M | 8.6M | Unchanged |
| BlackRock, Inc. | $15.8M | 7.8M | +23.2% |
| ADAR1 Capital Management, LLC | $15M | 7.4M | +11.8% |
| Blackstone Inc. | $12.1M | 5.9M | Unchanged |
| Siren, L.L.C. | $11.9M | 5.9M | Unchanged |
| Commodore Capital LP | $11M | 5.4M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $10M | 4.9M | +10.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.